ANA Testing Market — Global Forecast

By -

The Global Antinuclear Antibody Test Market is expected to reach USD 1,476.1 Million by 2021 from USD 823.5 Million in 2016, at a CAGR of 12.4%.

(EMAILWIRE.COM, February 21, 2019 ) The Research Report on ANA Testing Market provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the Antinuclear Antibody Test Market, along with revenue estimates & forecasts and market share analysis.

The increasing prevalence of autoimmune diseases and increasing healthcare expenditure worldwide are the major factors driving the growth of this ANA Testing Market.

Download PDF (Antinuclear Antibody Test Market):

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=218189007

This research report segments this ANA Testing Market based on products, diseases, techniques, end users, and regions.

In the products market, the assay kits & reagents segment is expected to account for the largest share. This segment is also expected to grow at the highest CAGR during the forecast period due to the growth in the number of reagent rental agreements and the increasing prevalence of autoimmune diseases worldwide.

ANA Testing Market Based on Product;

Based on products, the market is segmented into assay kits & reagents, systems, and software & services. The assay kits & reagents segment is expected to account for the largest share of the global ANA Testing market in 2016. The growth in this segment can majorly be attributed to the growth in the number of reagent rental agreements and the increasing prevalence of autoimmune diseases.

ANA Testing Market Based on techniques;

the market is segmented into enzyme-linked immunosorbent assay (ELISA), immunofluorescence assay (IFA), and multiplex assay. The ELISA segment is expected to account for the largest share of this market due to the expanding applications of ANA in autoimmune disease Testing and therapeutic drug level monitoring.

ANA Testing Market Based on end user;

The end user segments in the market include clinical laboratories, hospitals, POLs, and other end users. The hospital's segment is expected to account for the largest share of the global ANA Testing market in 2016. Growth in this segment can be attributed to the fact that most diagnostic tests are performed in hospitals or hospital-attached laboratories, primarily due to easy access to reports and smooth logistics.

Read More in Detailed (Antinuclear Antibody Test):

https://www.marketsandmarkets.com/Market-Reports/antinuclear-antibody-test-market-218189007.html

Media Contact

Related Tags

Read other news from MarketsandMarkets™

Timing Devices Market Size, Share, Revenue Trends & Forecast to 2030

MarketsandMarkets™ - Sep 18, 2023
Timing Devices Market by Type (Oscillators, Atomic Clocks, Clock Generators, Clock Buffers, Jitter Attenuators), Material (Crystal, Silicon, Ceramic), Vertical (Consumer Electronics, Automotive) and Region - Global Forecast to 2030 ...Read more

Artificial Intelligence Market Segmented by Product, Top Manufacturers, Geography Trends & Growth Opportunity to 2030

MarketsandMarkets™ - Sep 18, 2023
Artificial Intelligence technology such as machine learning, natural language processing, computer vision, and others are revolutionizing various sectors, including healthcare, finance, manufacturing, and retail. ...Read more

Digital PCR (dPCR) and Real-time PCR (qPCR) Market worth $12.4 billion by 2028, at a CAGR of 7.8%.

MarketsandMarkets™ - Sep 18, 2023
"Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product (Instruments, Reagents & Consumables, Software & Services), Application (Clinical, Research, Forensic), End User (Hospital, Diagnostic Labs, Pharma, Biotech, CROs) - Global Forecast to 2028". ...Read more